Atlas Trials

Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers

Clinical trial NCT07118176 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT07118176
Sponsor
Jonsson Comprehensive Cancer Center
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Anal CarcinomaBladder CarcinomaBreast CarcinomaCervical CarcinomaCholangiocarcinomaColorectal CarcinomaEsophageal CarcinomaGastric CarcinomaHead and Neck CarcinomaHematopoietic and Lymphatic System NeoplasmHepatocellular CarcinomaLung Carcinoma
Start date
2025-08-01
Primary completion
2026-09-06
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.